{"id":81131,"date":"2025-05-07T05:57:08","date_gmt":"2025-05-07T05:57:08","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/81131\/"},"modified":"2025-05-07T05:57:08","modified_gmt":"2025-05-07T05:57:08","slug":"des-milliers-de-boites-dun-traitement-contre-lhypertension-rappelees-en-france","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/81131\/","title":{"rendered":"Des milliers de bo\u00eetes d\u2019un traitement contre l\u2019hypertension rappel\u00e9es en France"},"content":{"rendered":"<p>Si vous avez du Lisinopril, il va \u00eatre n\u00e9cessaire de proc\u00e9der \u00e0 une v\u00e9rification. Plus de 32.000 bo\u00eetes de ce <a href=\"https:\/\/www.20minutes.fr\/dossier\/medicament\" target=\"_blank\" class=\"color-ultramarine c-link\" rel=\"noopener\">m\u00e9dicament<\/a> g\u00e9n\u00e9rique contre l\u2019hypertension et l\u2019insuffisance cardiaque ont \u00e9t\u00e9 rappel\u00e9es en France en raison d\u2019un \u00ab\u00a0d\u00e9faut d\u2019impression\u00a0\u00bb sur les plaquettes \u00ab\u00a0pouvant induire un risque de surdosage\u00a0\u00bb, a indiqu\u00e9 mardi l\u2019Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament (ANSM).<\/p>\n<p>La qualit\u00e9 des comprim\u00e9s commercialis\u00e9s par le <a href=\"https:\/\/www.20minutes.fr\/dossier\/industrie_pharmaceutique\" target=\"_blank\" class=\"color-ultramarine c-link\" rel=\"noopener\">laboratoire am\u00e9ricain<\/a> Viatris \u00ab\u00a0n\u2019est pas remise en cause\u00a0\u00bb mais \u00ab\u00a0l\u2019inscription pr\u00e9sente sur l\u2019aluminium de la plaquette peut pr\u00eater \u00e0 confusion car elle laisse penser qu\u2019il faut prendre plusieurs comprim\u00e9s certains jours\u00a0\u00bb, pr\u00e9cise l\u2019ANSM.<\/p>\n<p>Un cas de surdosage rapport\u00e9<\/p>\n<p>Au total, quatre lots de Lisinopril dos\u00e9s \u00e0 5\u00a0mg sont concern\u00e9s (lots 8172295, 8189879, 8172296, 8192737), soit 32.640 bo\u00eetes, selon un d\u00e9compte obtenu aupr\u00e8s de l\u2019ANSM.<\/p>\n<\/p>\n<p>En cas de surdosage, il est possible de ressentir de la fatigue, des troubles de l\u2019\u00e9quilibre, une hypotension et \u00ab\u00a0une alt\u00e9ration de la fonction r\u00e9nale peut survenir\u00a0\u00bb, pr\u00e9vient la gardienne du m\u00e9dicament. Un cas de surdosage accompagn\u00e9 d\u2019un \u00e9tat confusionnel non grave a \u00e9t\u00e9 rapport\u00e9, selon l\u2019ANSM.<\/p>\n<p><a href=\"https:\/\/www.20minutes.fr\/sante\/\" target=\"_blank\" class=\"c-link c-btn c-btn--primary\" rel=\"noopener\">Notre dossier Sant\u00e9<\/a><\/p>\n<p>En attendant que de nouveaux lots avec des plaquettes conformes soient \u00ab\u00a0prochainement disponibles\u00a0\u00bb, aucune tension d\u2019approvisionnement en Lisinopril n\u2019est pr\u00e9vue suite \u00e0 ce rappel, selon l\u2019agence, car \u00ab\u00a0des alternatives sont disponibles\u00a0\u00bb. D\u2019autres g\u00e9n\u00e9riques, comme Biogaran, Teva, Zentiva, Sandoz ou Arrow proposent cette mol\u00e9cule, selon la base de donn\u00e9es Vidal sur les m\u00e9dicaments en France.<\/p>\n","protected":false},"excerpt":{"rendered":"Si vous avez du Lisinopril, il va \u00eatre n\u00e9cessaire de proc\u00e9der \u00e0 une v\u00e9rification. Plus de 32.000 bo\u00eetes&hellip;\n","protected":false},"author":2,"featured_media":81132,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[47,1011,27,72,225,71,5699,227,133],"class_list":{"0":"post-81131","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-sante","8":"tag-actualite","9":"tag-fr","10":"tag-france","11":"tag-health","12":"tag-medicament","13":"tag-sante","14":"tag-sante-publique","15":"tag-traitement","16":"tag-video"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/114465016597492139","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/81131","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=81131"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/81131\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/81132"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=81131"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=81131"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=81131"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}